COVID_19 vaccie

India prepares 600 million COVID-19 vaccine doses using standard cold storage

Serum Institute of India COVID-19 Vaccine advances to trial for phase-III on 1500 Indian patients

Upon clearance, Oxford vaccine manufactured by Serum Institute will be tested on 1500 patients at 14 locations.

UK Pharmaceutical company AstraZeneca stops Coronavirus vaccine trial after unforeseen illness in voluntary

Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomised clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.

Serum Institute CEO, Adar Poonawalla remains optimistic on development of Oxford COVID-19 Vaccine

The Serum Institute is the world’s largest manufacturer of vaccines by volume and has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute of Oxford University.